Abbott Scoops Up Kalila Medical

Abbott is on an acquisition spree. After announcing plans to shell out $5.8 billion for Alere, the company says it has snagged Kalila Medical for an undisclosed amount of money.

With the acquisition, Abbott gains technology to expand its portfolio of tools to treat atrial fibrillation and other heart rhythm disorders, the company says.

Kalila, headquartered in Campbell, Calif., has developed a novel steerable sheath that helps physicians access and perform catheter-based electrophysiology procedures.

Kalila received 510(k) clearance from the FDA for its steerable introducer sheath in 2014 and received the CE Mark in December 2013. — Jonathon Shacat